Immunotech inc stock
WitrynaAIM ImmunoTech Inc. (AMEX: AIM) stock closed at 0.495 per share at the end of the most recent trading day (a -2.83 % change compared to the prior day closing price) with a volume of 94.83K shares and market capitalization of 20.64M.Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology … Witryna27 mar 2024 · AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including COVID-19, the disease caused by the SARS-CoV-2 virus — today announced that it …
Immunotech inc stock
Did you know?
Witryna31 mar 2024 · AIM ImmunoTech Inc. comunicó los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2024. Para el año completo, la empresa declaró unos ingresos de 0,141 millones de USD frente a … WitrynaOctober 21, 2024 Fourth Amendment to Agreement of Sale and Purchase with Acellories, Inc * Amendment to the November 14, 2024 Second Amended and Restated Rights Agreement as of November 9, 2024, by and between AIM ImmunoTech Inc. (f/k/a Hemispherx Biopharma, Inc.) and American Stock Transfer & Trust Company, LLC.
Witryna11 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and … Witryna11 kwi 2024 · The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AIM ImmunoTech Inc 50-day moving average is $0.4869.
Witryna6 kwi 2024 · Of the 21 institutional investors that purchased AIM ImmunoTech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Morgan Stanley ($1.51M), Renaissance Technologies LLC ($0.48M), BlackRock Inc. ($0.47M), State Street Corp ($0.17M), Dimensional Fund Advisors LP … WitrynaWith Aim Immunotech stock trading at $0.43 per share, the total value of Aim Immunotech stock (market capitalization) is $20.68M.Aim Immunotech. stock was originally listed at a price of in Dec 31, 1997. If you had invested in Aim Immunotech stock at , your return over the last 25 years would have been -99.98%, for an …
Witryna12 kwi 2024 · AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. brackin and johnson pcWitrynaStock analysis for Immunotech Laboratories Inc (IMMB:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. h2 hen\u0027s-footWitrynaAIM ImmunoTech Shareholders Elect All Three Company Director Nominees at 2024 Annual Meeting. OCALA, Fla., November 03, 2024--AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced that shareholders have re-elected all three of the Company’s directors, Stewart L. Appelrouth, Thomas K. … brackin appliances enterprise alabamaWitryna12 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and … h2 hemisphere\\u0027sWitryna9 kwi 2024 · AIM ImmunoTech Inc. (AMEX ... In a free sample issue of our monthly newsletter we analyzed Warren Buffett’s stock picks covering the 1999-2024 period … h2 helsingborgWitryna3 mar 2024 · Get Immunotech Laboratories Inc (IMMB:Over The Counter Mkt) real-time stock quotes, news, price and financial information from CNBC. h2he gasWitrynaAIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of … h2h entertainment pty ltd